Lower urinary tract symptoms and drugs of ingredients of cefazolin sodium - a phase IV clinical study of FDA data


Summary:

Lower urinary tract symptoms is reported only by a few people who take drugs with ingredients of cefazolin sodium. This phase IV clinical study analyzes 16,446 people who have side effects while taking drugs with ingredients of cefazolin sodium from the the FDA. Among them, 2 have Lower urinary tract symptoms. Find out below who they are, when they have Lower urinary tract symptoms and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Ancef, Ancef in dextrose 5% in plastic container, Ancef in plastic container, Ancef in sodium chloride 0.9% in plastic container, Cefazolin, Cefazolin and dextrose, Cefazolin in plastic container, Cefazolin sodium, Kefzol.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Nov, 30, 2022

16,446 people reported to have side effects when taking drugs with ingredients of cefazolin sodium.
Among them, 2 people (0.01%) have Lower urinary tract symptoms


What is Lower urinary tract symptoms?

Lower urinary tract symptoms is found to be associated with 224 drugs and 103 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of cefazolin sodium cause Lower urinary tract symptoms?

Gender of people who have Lower urinary tract symptoms when taking drugs with ingredients of cefazolin sodium *:

  • female: 0.0 %
  • male: 100 %

Conditions people have *:

  1. Dizziness: 1 person, 50.00%
  2. Cellulitis (infection under the skin): 1 person, 50.00%
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 50.00%
  4. Bladder Outlet Obstruction (urological condition where the urine flow from the urinary bladder through the urethra is impeded): 1 person, 50.00%

Other drugs people take *:

  1. Aspirin: 2 people, 100.00%
  2. Furosemide: 2 people, 100.00%
  3. Zocor: 1 person, 50.00%
  4. Doxycycline: 1 person, 50.00%
  5. Isordil: 1 person, 50.00%
  6. Hyzaar: 1 person, 50.00%
  7. Hytrin: 1 person, 50.00%
  8. Glucotrol: 1 person, 50.00%
  9. Glucophage: 1 person, 50.00%
  10. Glipizide: 1 person, 50.00%

Other side effects people have besides Lower urinary tract symptoms *:

  1. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 50.00%
  2. Dehydration (dryness resulting from the removal of water): 1 person, 50.00%
  3. Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 1 person, 50.00%
  4. Left Ventricular Dysfunction: 1 person, 50.00%
  5. Laboratory Test Abnormal: 1 person, 50.00%
  6. Insomnia (sleeplessness): 1 person, 50.00%
  7. Hypoaesthesia (reduced sense of touch or sensation): 1 person, 50.00%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 50.00%
  9. Headache (pain in head): 1 person, 50.00%
  10. Enlarged Prostate: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.


How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: